Joel F. Oger

BC V6T1Z4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Journal: Brain : a journal of neurology

Published: February 11, 2026

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.

Journal: BMJ open

Published: September 19, 2020

Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies.

Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies.

Journal: Frontiers in neurology

Published: August 19, 2020

Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study.

Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study.

Journal: Neuroepidemiology

Published: August 16, 2019

Minimal manifestation status and prednisone withdrawal in the MGTX trial.

Minimal manifestation status and prednisone withdrawal in the MGTX trial.

Journal: Neurology

Published: June 14, 2019

Multiple sclerosis: effect of beta interferon treatment on survival.

Multiple sclerosis: effect of beta interferon treatment on survival.

Journal: Brain : a journal of neurology

Published: September 29, 2018

Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.

Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 16, 2018

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.

Journal: The Lancet. Neurology

Published: April 20, 2018

Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme.

Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: March 06, 2018

Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.

Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.

Journal: Health technology assessment (Winchester, England)

Published: November 08, 2016

Randomized Trial of Thymectomy in Myasthenia Gravis.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Journal: The New England journal of medicine

Published: August 11, 2016

Disability progression in aggressive multiple sclerosis.

Disability progression in aggressive multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 22, 2016

Showing 1-12 of 48

Last Updated: 09/26/2026